ASTELLAS PHARMA A/S: Financial statements 2022
CVR: 10888638
Source: annual report 2022, Danish Business Authority
01/04/2021 – 31/03/2022
ASTELLAS PHARMA A/S (CVR 10888638) has filed annual accounts for 2022. In 2022, the company reported revenue of EUR 179,933,000 and a net result of EUR 6,689,000 compared with EUR 5,865,000 the year before. That is an increase of 12.1% compared with the year before. The profit margin was 3.7%. Equity in the 2022 report amounted to EUR 58,226,000. The solvency ratio was 16.8%. The company had 120 employees in the financial year.
- Revenue
- EUR 179,933,000
- Gross Profit
- EUR 26,175,000
- Profit/Loss
- EUR 6,689,000
- Equity
- EUR 58,226,000
- Total Assets
- EUR 345,591,000
- Employees
- 120
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 179.9M EUR | 26.2M EUR | 6.7M EUR | 58.2M EUR | 120 |
| 2021 | 160.5M EUR | 24.1M EUR | 5.9M EUR | 59.4M EUR | 115 |
| 2020 | 187M EUR | 23.8M EUR | 2M EUR | 53.6M EUR | 114 |
| 2019 | 182.6M EUR | 25M EUR | 4.7M EUR | 56.2M EUR | 116 |
| 2018 | 157.8M EUR | 20.5M EUR | 2.6M EUR | 54.1M EUR | 115 |
Official annual report
Keep an eye on ASTELLAS PHARMA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of October 6, 2022, Damla Ebru Atilgan has joined the board of directors of ASTELLAS PHARMA A/S.
As of October 6, 2022, Yagnaram Santharam has left the board of directors of ASTELLAS PHARMA A/S.
About ASTELLAS PHARMA A/S
ASTELLAS PHARMA A/S is a Danish company of the type Aktieselskab based in København S, founded in 1987. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named YAMANOUCHI PHARMA A/S and BROCADES PHARMA A/S. The management consists of Mark Andree Dekker. The board consists of Damla Ebru Atilgan (chair), Anne Nymand, Giuseppe Maduri and Mark Andree Dekker. The company is owned by Astellas Pharma Europe LTD.. The company has 67 employees (2026). In 2026, the company reported revenue of EUR 197,863,000 and a net result of EUR 5,229,000 compared with EUR 5,705,000 the year before. Equity in the 2026 report amounted to EUR 20,071,000.